Imagine a tiny, high-tech needle that uses sound waves to blast through hard calcium blockages in your leg arteries. It's like using a sonic drill to clear a clogged pipe so that blood can flow again. This helps doctors save legs that would otherwise have to be amputated because the blockage was too hard to pass through.
Endovascular surgeons struggle to pass guidewires through severely calcified artery blockages, often taking 30-60 minutes or failing entirely. This leads to high rates of limb amputation and poor patient survival.
An ultrasound-based crossing system (FastWire) designed to penetrate calcium and plaque in arteries to allow subsequent treatment with stents or balloons.
If you are a device manufacturer dealing with the rise of complex chronic total occlusions — this project developed a crossing system that uses ultrasound to penetrate plaque. This allows physicians to cross 90% of occlusions within 10 minutes, significantly reducing procedure time.
If you are a clinic dealing with the fact that 30% of CLTI patients face amputation in the first year — this project developed the FastWire tool. It enables less experienced physicians to safely cross blockages, expanding the number of patients who can receive endovascular therapy.
If you are a health system dealing with PAD prevalence increasing up to 3.14% in some regions — this project developed a tool to treat smaller, calcified arteries. This reduces the need for expensive open surgeries and the high cost of long-term amputation care.
Based on available project data, the specific unit cost or pricing model for the device is not mentioned.
The project is funded under the EIC Accelerator, which typically supports the scale-up of innovations, but specific manufacturing capacity data is not provided.
Based on available project data, the technology is developed by Versono Medical Limited, but specific licensing terms are not disclosed.
The project period runs from 2023-03-01 to 2025-03-31, suggesting a development and validation window ending in early 2025.
The device acts as a crossing tool that enables physicians to then apply other treatments like stents, balloons, or atherectomy devices to unblock the artery.
The project is led by a single SME, Versono Medical Limited from Ireland. With a 100% industry ratio and no university or research partners, the project is focused entirely on commercial product development and rapid market entry rather than basic academic research.
Contact Versono Medical Limited in Ireland for partnership inquiries.
Contact us to track the commercial launch of the FastWire system.
